{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:53:07Z","timestamp":1781484787772,"version":"3.54.1"},"reference-count":25,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Sage Open Medicine"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>To determine the prevalence and underlying causes of nonglaucomatous optic atrophy (NGOA) in a tertiary referral center in southeastern Iran and to identify predictors of current visual acuity in this population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this descriptive cross-sectional study, patients with a confirmed diagnosis of NGOA were included. All cases had a definitive etiologic diagnosis based on clinical evaluation, paraclinical investigations, and thorough review of medical records. Patients were classified into etiologic categories including hereditary or developmental disorders; secondary or consecutive optic atrophy; traumatic optic neuropathy (TON); compressive lesions; raised intracranial pressure\u2013related involvement; inflammatory or demyelinating disease; infiltrative processes; toxic exposure; and ischemic causes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 155 eyes from 155 patients with NGOA were analyzed, of whom 86 (55.5%) were male. Overall, 75 patients (48.4%) had a best-corrected visual acuity (BCVA) of \u2265 1.90 logMAR (logarithm of the minimum angle of resolution), corresponding to counting fingers vision or worse. Patients with toxic optic neuropathy demonstrated the poorest visual outcomes, with 5 of 6 cases (83.3%) having a BCVA of \u2265 1.90 logMAR. Ischemic causes were the most prevalent etiology, identified in 46 patients (29.7%), including 45 cases of non-arteritic anterior ischemic optic neuropathy (AION). TON was the second most common cause, observed in 37 patients (23.9%). In multivariate analysis, a longer duration from symptom onset was the sole independent predictor of poorer current visual acuity (\u03b2 = 0.253,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.010).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Previous non-arteritic AION was the most common cause of NGOA in this cohort, followed by TON. Toxic exposure was associated with the poorest visual acuities. Among all evaluated variables, the duration from symptom onset was the only independent predictor of current visual acuity.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/20503121261461345","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T22:57:41Z","timestamp":1781218661000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Etiologic spectrum and predictors of visual acuity in non-glaucomatous optic atrophy"],"prefix":"10.1177","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2784-824X","authenticated-orcid":false,"given":"Meraj","family":"Sharifi","sequence":"first","affiliation":[{"name":"Kerman University of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4423-4979","authenticated-orcid":false,"given":"Amin","family":"Zand","sequence":"additional","affiliation":[{"name":"Kerman University of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9044-3272","authenticated-orcid":false,"given":"Mohammad","family":"Sharifi","sequence":"additional","affiliation":[{"name":"Kerman University of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0713-088X","authenticated-orcid":false,"given":"Ali","family":"Sharifi","sequence":"additional","affiliation":[{"name":"Kerman University of Medical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,6,11]]},"reference":[{"key":"e_1_3_6_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2005.00541.x"},{"key":"e_1_3_6_3_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-022-02350-1"},{"key":"e_1_3_6_4_2","doi-asserted-by":"publisher","DOI":"10.5144\/0256-4947.2017.232"},{"key":"e_1_3_6_5_2","doi-asserted-by":"publisher","DOI":"10.3126\/nepjoph.v13i1.29035"},{"key":"e_1_3_6_6_2","first-page":"11","article-title":"Epidemiology of optic atrophy among the patients attending a tertiary care hospital, ongole, prakasham district, AP","volume":"3","author":"Babu Rao DBKC","year":"2016","unstructured":"Babu Rao DBKC. Epidemiology of optic atrophy among the patients attending a tertiary care hospital, ongole, prakasham district, AP. Int J Contemp Med Res 2016; 3: 11.","journal-title":"Int J Contemp Med Res"},{"issue":"1","key":"e_1_3_6_7_2","first-page":"1","article-title":"Omaka, Uma Andrew and OGI. Prevalence of Non-Glaucomatous Optic Atrophy in Ehime Mbano, Nigeria","volume":"3","author":"Ihesiulor GC","year":"2020","unstructured":"Ihesiulor GC, Chimchetam JN, Udo UA, et al. Omaka, Uma Andrew and OGI. Prevalence of Non-Glaucomatous Optic Atrophy in Ehime Mbano, Nigeria. Asian J Res Reports Ophthalmol 2020; 3(1): 1\u20139.","journal-title":"Asian J Res Reports Ophthalmol"},{"key":"e_1_3_6_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2010.03.005"},{"issue":"0","key":"e_1_3_6_9_2","first-page":"120","article-title":"Optic Neuropathies in Iran","volume":"2","author":"Abri Aghdam K","year":"2021","unstructured":"Abri Aghdam K, Aghajani A, Kiarudi MY, et al. Optic Neuropathies in Iran. Arch Persian Ophthalmol 2021; 2(0): 120\u2013137. https:\/\/apo.tums.ac.ir\/article-1-38-en.html (Accessed 14 December 2025).","journal-title":"Arch Persian Ophthalmol"},{"key":"e_1_3_6_10_2","doi-asserted-by":"publisher","DOI":"10.3341\/kjo.2012.26.2.80"},{"key":"e_1_3_6_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/aos.14659"},{"key":"e_1_3_6_12_2","unstructured":"Section 5: Neuro-Ophthalmology. In: American Academy of Ophthalmology\u2019s Basic and Clinical Science Course (BCSC) Vol 160."},{"key":"e_1_3_6_13_2","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-4-7"},{"key":"e_1_3_6_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2009.04.002"},{"key":"e_1_3_6_15_2","first-page":"93","article-title":"The spectrum of optic disc ischemia in patients younger than 50 years (an Amercian Ophthalmological Society thesis)","volume":"111","author":"Arnold AC","year":"2013","unstructured":"Arnold AC, Costa RMS, Dumitrascu OM. The spectrum of optic disc ischemia in patients younger than 50 years (an Amercian Ophthalmological Society thesis). Trans Am Ophthalmol Soc 2013; 111: 93\u2013118. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24167327","journal-title":"Trans Am Ophthalmol Soc"},{"key":"e_1_3_6_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/00006534-200106000-00003"},{"key":"e_1_3_6_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/SCS.0b013e31824cd4a7"},{"key":"e_1_3_6_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2009.79"},{"key":"e_1_3_6_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjtee.2024.02.004"},{"key":"e_1_3_6_20_2","doi-asserted-by":"publisher","DOI":"10.1177\/1120672119899378"},{"key":"e_1_3_6_21_2","doi-asserted-by":"publisher","DOI":"10.4103\/0301-4738.145996"},{"key":"e_1_3_6_22_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318271f755"},{"key":"e_1_3_6_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(17)30393-5"},{"key":"e_1_3_6_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(13)70113-X"},{"key":"e_1_3_6_25_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awae324"},{"key":"e_1_3_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(87)33349-4"}],"container-title":["Sage Open Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20503121261461345","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/20503121261461345","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/20503121261461345","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:17:12Z","timestamp":1781482632000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/20503121261461345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":25,"alternative-id":["10.1177\/20503121261461345"],"URL":"https:\/\/doi.org\/10.1177\/20503121261461345","relation":{},"ISSN":["2050-3121","2050-3121"],"issn-type":[{"value":"2050-3121","type":"print"},{"value":"2050-3121","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]},"article-number":"20503121261461345"}}